139 related articles for article (PubMed ID: 10783183)
1. Effects of substance dependence on outcomes of patients in a randomized trial of two case management models.
Havassy BE; Shopshire MS; Quigley LA
Psychiatr Serv; 2000 May; 51(5):639-44. PubMed ID: 10783183
[TBL] [Abstract][Full Text] [Related]
2. Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients.
Havassy BE; Arns PG
Psychiatr Serv; 1998 Jul; 49(7):935-40. PubMed ID: 9661229
[TBL] [Abstract][Full Text] [Related]
3. Outcome of planned discharge from case management: a 3 year retrospective study.
Backus L; Weinkove J; Lucas M; Jespersen S
Australas Psychiatry; 2008 Feb; 16(1):33-8. PubMed ID: 17957526
[TBL] [Abstract][Full Text] [Related]
4. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of assertive community treatment versus standard case management for persons with co-occurring severe mental illness and substance use disorders.
Clark RE; Teague GB; Ricketts SK; Bush PW; Xie H; McGuire TG; Drake RE; McHugo GJ; Keller AM; Zubkoff M
Health Serv Res; 1998 Dec; 33(5 Pt 1):1285-308. PubMed ID: 9865221
[TBL] [Abstract][Full Text] [Related]
6. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
[TBL] [Abstract][Full Text] [Related]
7. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
Goeb JL; Coste J; Bigot T; Ferrand I
Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
[TBL] [Abstract][Full Text] [Related]
8. Short-term outcomes of matching dual diagnosis patients' symptom severity to treatment intensity.
Timko C; Sempel JM
J Subst Abuse Treat; 2004 Apr; 26(3):209-18. PubMed ID: 15063915
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of an integrated cognitive behaviour therapy (CBT) treatment program for co-occurring depression and substance misuse in young people.
Hides L; Carroll S; Catania L; Cotton SM; Baker A; Scaffidi A; Lubman DI
J Affect Disord; 2010 Feb; 121(1-2):169-74. PubMed ID: 19604584
[TBL] [Abstract][Full Text] [Related]
10. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
Brunette MF; Noordsy DL; Xie H; Drake RE
Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
[TBL] [Abstract][Full Text] [Related]
11. Dual diagnosis in an Australian forensic psychiatric hospital: prevalence and implications for services.
Ogloff JR; Lemphers A; Dwyer C
Behav Sci Law; 2004; 22(4):543-62. PubMed ID: 15282839
[TBL] [Abstract][Full Text] [Related]
12. Remission of psychiatric symptoms among drug misusers after drug dependence treatment.
Gossop M; Marsden J; Stewart D
J Nerv Ment Dis; 2006 Nov; 194(11):826-32. PubMed ID: 17102706
[TBL] [Abstract][Full Text] [Related]
13. Psychiatric hospital outcomes of dual diagnosis patients under managed care.
Leon SC; Lyons JS; Christopher NJ; Miller SI
Am J Addict; 1998; 7(1):81-6. PubMed ID: 9522010
[TBL] [Abstract][Full Text] [Related]
14. The influence of neighborhood environment on treatment continuity and rehospitalization in dually diagnosed patients discharged from acute inpatient care.
Stahler GJ; Mennis J; Cotlar R; Baron DA
Am J Psychiatry; 2009 Nov; 166(11):1258-68. PubMed ID: 19797433
[TBL] [Abstract][Full Text] [Related]
15. [Dual diagnosis in psychoactive substance abusing or dependent persons].
Błachut M; Badura-Brzoza K; Jarzab M; Gorczyca P; Hese RT
Psychiatr Pol; 2013; 47(2):335-52. PubMed ID: 23888766
[TBL] [Abstract][Full Text] [Related]
16. Psychiatric comorbidity in forensic psychiatry.
Palijan TZ; Muzinić L; Radeljak S
Psychiatr Danub; 2009 Sep; 21(3):429-36. PubMed ID: 19794370
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in the assessment of specialized treatments for substance abuse among people with severe mental illness.
Jerrell JM; Ridgely MS
J Psychoactive Drugs; 1995; 27(4):347-55. PubMed ID: 8788691
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic limit setting in an assertive community treatment program.
Neale MS; Rosenheck RA
Psychiatr Serv; 2000 Apr; 51(4):499-505. PubMed ID: 10737826
[TBL] [Abstract][Full Text] [Related]
19. Transition to low intensity case management in a VA Assertive Community Treatment model program.
Rosenheck RA; Neale MS; Mohamed S
Psychiatr Rehabil J; 2010; 33(4):288-96. PubMed ID: 20374987
[TBL] [Abstract][Full Text] [Related]
20. The MICA Case Conference Program at Tewksbury Hospital, Mass.: an integrated treatment model.
Clodfelter RC; Albanese MJ; Baker G; Domoto K; Gui AL; Khantzian EJ
Am J Addict; 2003; 12(5):448-54. PubMed ID: 14660158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
